Launch of Easydrip™ Plus Pen Needles in Uzbekistan
In a significant development for the healthcare sector in Uzbekistan, Sandstone Medical, a subsidiary of SteriLance Medical, has officially launched its Easydrip™ Plus needle series in the country. This innovation aims to provide a patient-friendly alternative in a market traditionally divided between expensive international brands and lower-quality products.
Bridging the Quality Gap
The Easydrip™ Plus needles are designed with a large platform to ensure stability during insertion, promoting better control. The polished, multifunctional needles feature thin walls that allow for a smooth and gentle insertion while maintaining reliable flow rates. This design not only alleviates anxiety associated with self-administered injections but also enhances adherence to treatment.
Practical Specifications
Available in various sizes and lengths, these single-use needles are compatible with widely-used insulin pens and sterile packaging. Sandstone emphasizes practicality with clear usage instructions and pharmacy-friendly packaging, ensuring a user-centric approach.
Easydrip™ Plus needles are now accessible in major hospital and pharmacy networks across Uzbekistan, with a gradual rollout in additional cities. Local partners will receive educational materials targeted toward healthcare professionals and individuals managing diabetes. Initial feedback highlights the ease of use and consistent performance, signaling a positive reception in the market.
Expanding Accessibility
To further enhance accessibility, Sandstone plans to boost its online presence and facilitate influencer-led education campaigns. A company spokesperson stated, "Our aim is to balance a top-tier experience with availability, providing patients in Uzbekistan with a safer and more comfortable way to administer daily injections."
Compliance and Certification
The Easydrip™ Plus needles are manufactured under a stringent quality management system ISO 13485 and hold the CE certification, ensuring compliance with international safety and performance standards. This commitment to quality positions Sandstone as a reliable player in the healthcare market.
About Sandstone Medical and SteriLance Medical
Sandstone Medical is dedicated to developing patient-centered self-care solutions for diabetes under the SteriLance Medical brand. Founded in 1993, SteriLance holds over 200 global patents and distributes its products in more than 50 countries.
For more information, visit
Sandstone Medical or
SteriLance Medical. Inquiries can be directed to
[email protected].
By bridging the gap between premium and budget options, Sandstone’s Easydrip™ Plus offers a forward-thinking way to improve patient care in Uzbekistan, enhancing the overall experience of injecting therapies for diabetes management.